<p>Low level light therapy for the treatment of recalcitrant chalazia: a sample case summary</p>

Abstract

PurposeTo evaluate the effects of low-level light therapy (LLLT) on the resolution of recalcitrant chalazia.Patients and MethodsThis was a single-site retrospective chart review of patients with chalazia, all of whom were unresponsive to previous pharmaceutical therapy or surgical intervention, who received a 15 min LLLT treatment in conjunction with a standard pharmaceutical regimen. A second treatment was applied 24 hrs to as late as 2 months if there was no evidence of progression of resolution in appearance.ResultsA total of 26 eyes of 22 patients with relevant history and treatment were reviewed, all with a history of prior pharmaceutical treatment for their chalazia. After a single 15 min LLLT treatment, followed by a standard pharmaceutical regimen, 46% of eyes (12/26) showed resolution of their chalazia. Resolution was noted from 3 days to one-month post-treatment. With a second treatment, the chalazia resolved in 92% of eyes (24/26). Only two eyes of the 26 (8%) required incision and curettage after LLLT treatment.ConclusionThe use of LLLT for the treatment of recalcitrant chalazia appears to be beneficial in patients who have failed topical and/or systemic therapy, significantly reducing the likelihood of requiring surgical intervention.

Effect of low-level light therapy in patients with dry eye: a prospective, randomized, observer-masked trial

“…Our study has shown a decrease in dry eye symptom, suggesting that LLLT can be used for lacrimal and meibomian gland alterations. LLLT is widely used by dermatologists, plastic surgeons and other specialties due to its analgesic, anti-inflammatory, and biostimulatory effects, and recent reports have shown the efficacy of a combination of LLLT with intense pulsed light (IPL) therapy for meibomian gland dysfunction, and LLLT on its own in the treatment of chalazia 7 , 14 , 31 . Evidence has therefore started to accrue for the safety and efficacy of LLLT on ophthalmic tissues, and we believe that our study has added to that evidence.…”

Photobiomodulation (low-level light therapy) and dry eye disease

“…The photobiomodulation mask is equipped with a matrix of light-emitting diodes producing light at a wavelength of 633 ± 10 nm and power of 100 mW/cm 2 (Figure 1B). 51 When applied for 15 minutes, this equates to an energy density of 90 Joules/cm 2 over the treatment area. Some degree of generalised, exogenous heating typically accompanies use of the mask.…”

“…In a single-site, retrospective, chart review of 26 eyes from 22 patients with chalazia unresponsive to pharmaceutical or surgical therapy, a 15 min photobiomodulation therapy treatment was conducted in conjunction with antibiotic/steroid eye drops for two weeks. 51 All adults were also prescribed 100 mg oral doxycycline twice daily.…”

Comparison of intralesional injection of triamcinolone - 40 mg/ml and Triamcinolone -10 mg/ml in treatment of chalazion

“…3 Common modalities of treatment for chalazion are Simple observation with hot moist compression, 5 Conservative management by hot moist compression, meticulous lid hygiene with topical antibiotic or antibiotic steroid medication for a period of six weeks, 5,6 intralesional depot steroid injection, 7 Surgical intervention (incision-curettage, subconjunctival excision and tarasal trephination), 2,8 and combined surgery with intralesional steroid injection, 9 Also uncommon procedures like Co2 laser treatment followed by curette, 10 intralesional injection of Botolinum toxin -A 11 and Low level light therapy. 12 Advantages of intralesional TMA injections are simple outpatient department (OPD) procedure, no anesthesia injection requirement, minimal bleeding, no post procedure scarring, multiple chalazion can be treated at a time , easy to treat chalazion near punctual area and usefull in children and anxietic patients. 2,3 Many studies have been done on the efficacy and complications of TMA injection with various concentration and number of injections, 6,7,13 comparing the response with size of the chalazion, 14 duration of the chalazion, 5,6 gender and between different age group.…”